Literature DB >> 1723019

Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury.

C J Garrison1, P M Dougherty, K C Kajander, S M Carlton.   

Abstract

The change in staining density of glial fibrillary acidic protein (GFAP) was analyzed in rats that sustained a chronic constriction injury produced by sutures tied loosely around one sciatic nerve. This injury model of peripheral neuropathy resulted in a behavioral hyperalgesia evidenced by a decrease in mean foot withdrawal latency to radiant heat. Increased GFAP immunostaining was observed in the gray matter of the spinal cord ipsilateral to the lesion and specific to spinal segments in which the sciatic nerve is distributed. Elevated GFAP staining density was attributed primarily to hypertrophy of astrocytes rather than their proliferation or migration since counts of astrocyte profiles demonstrated no significant difference when comparing the lesioned to the control side. The magnitude of the increase in GFAP staining correlated with the degree of hyperalgesia. Thus, these data suggest that astrocytes participate in the sequelae occurring in the dorsal horn following constriction injury of a peripheral nerve.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1723019     DOI: 10.1016/0006-8993(91)91729-k

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  110 in total

Review 1.  Role of astrocytes in pain.

Authors:  C-Y Chiang; B J Sessle; J O Dostrovsky
Journal:  Neurochem Res       Date:  2012-05-26       Impact factor: 3.996

2.  Spinal injection of TNF-α-activated astrocytes produces persistent pain symptom mechanical allodynia by releasing monocyte chemoattractant protein-1.

Authors:  Yong-Jing Gao; Ling Zhang; Ru-Rong Ji
Journal:  Glia       Date:  2010-11-15       Impact factor: 7.452

3.  Spinal expression of Hippo signaling components YAP and TAZ following peripheral nerve injury in rats.

Authors:  Na Li; Grewo Lim; Lucy Chen; Michael F McCabe; Hyangin Kim; Shuzhuo Zhang; Jianren Mao
Journal:  Brain Res       Date:  2013-08-30       Impact factor: 3.252

4.  Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain.

Authors:  M J Schwei; P Honore; S D Rogers; J L Salak-Johnson; M P Finke; M L Ramnaraine; D R Clohisy; P W Mantyh
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

Review 5.  Toll-like receptors in chronic pain.

Authors:  Lauren Nicotra; Lisa C Loram; Linda R Watkins; Mark R Hutchinson
Journal:  Exp Neurol       Date:  2011-10-06       Impact factor: 5.330

6.  Possible role of spinal astrocytes in maintaining chronic pain sensitization: review of current evidence with focus on bFGF/JNK pathway.

Authors:  Ru-Rong Ji; Yasuhiko Kawasaki; Zhi-Ye Zhuang; Yeong-Ray Wen; Isabelle Decosterd
Journal:  Neuron Glia Biol       Date:  2006-11

7.  Effects of Repetitive Transcranial Magnetic Stimulation on Astrocytes Proliferation and nNOS Expression in Neuropathic Pain Rats.

Authors:  Lu Yang; Sai-Hua Wang; Yan Hu; Yan-Fang Sui; Tao Peng; Tie-Cheng Guo
Journal:  Curr Med Sci       Date:  2018-06-22

8.  Effects of distal nerve injuries on dorsal-horn neurons and glia: relationships between lesion size and mechanical hyperalgesia.

Authors:  J W Lee; S M Siegel; A L Oaklander
Journal:  Neuroscience       Date:  2008-10-11       Impact factor: 3.590

9.  Glutamate-mediated astrocyte-to-neuron signalling in the rat dorsal horn.

Authors:  Rita Bardoni; Alessia Ghirri; Micaela Zonta; Chiara Betelli; Giovanni Vitale; Valentina Ruggieri; Maurizio Sandrini; Giorgio Carmignoto
Journal:  J Physiol       Date:  2010-01-18       Impact factor: 5.182

10.  A comparative transcriptomic analysis of astrocytes differentiation from human neural progenitor cells.

Authors:  Marco Magistri; Nathalie Khoury; Emilia Maria Cristina Mazza; Dmitry Velmeshev; Jae K Lee; Silvio Bicciato; Pantelis Tsoulfas; Mohammad Ali Faghihi
Journal:  Eur J Neurosci       Date:  2016-09-25       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.